Showing results (191-200 of 200) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trialJ D Hainsworth, H A Burris, D A Yardley, et al.Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesisP J Hesketh, W H Harvey, W G Harker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomitingT M Beck, P J Hesketh, S Madajewicz, et al.Cancer|October 12, 2001
Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research NetworkF A Greco, H A Burris, J R Gray, et al.Cancer|March 15, 1997
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study GroupE B Rubenstein, R J Gralla, J D Hainsworth, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2015
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†C Casulo, B Day, K L Dawson, et al.Cancer|April 3, 1999
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaJ D Hainsworth, H A Burris, J B Erland, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulationF M Muggia, J D Hainsworth, S Jeffers, et al.Cancer|March 26, 1999
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinomaM L Rothenberg, J V Cox, R F DeVore, et al.Pageof 20